Article
Pfizer RSV vaccine 82% effective vs severe infection in infants, final data shows (April 5)
Rating:
0.0
Views:
51
Likes:
1
Library:
1
Pfizer Inc's experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing severe infections in infants when given to expecting mothers in the second half of their pregnancy, according to trial details published on Wednesday that confirm preliminary data from the study.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value